Combination chemotherapy with epirubicin and cisplatin in ovarian carcinoma
โ Scribed by L. C. Fuith; A. Bazzanella; H. Hetzel
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 319 KB
- Volume
- 244
- Category
- Article
- ISSN
- 0003-9128
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Combination chemotherapy with Adriamycin-cyclophosphamide was employed after surgical treatment in 60 women with Stage 111-IV ovarian adenocarcinoma. Of 53 evaluable patients, objective response was noted in 34 of 41 (83%) without prior cytotoxic therapy but in only two of 12 (17%) who had failed a
## Background: The combination of paclitaxel with cisplatin or carboplatin has become the preferred chemotherapy regimen in the treatment of epithelial ovarian carcinoma. anthracyclines also have activity in this disease. we conducted a phase ii study by using the combination of paclitaxel, cisplat